Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
NCT00728078
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Liver Cancer
Interventions
DRUG:
thalidomide
Sponsor
Sun Yat-sen University